Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HLA associations with infliximab-induced liver injury.

The pharmacogenomics journal - 1 Oct 2020

Bruno Christopher D, Fremd Brandon, Church Rachel J, Daly Ann K, Aithal Guruprasad P, Björnsson Einar S, Larrey Dominique, Watkins Paul B, Chow Christina R

Abstract excerpt

Biomarkers that are able to identify patients at risk of drug-induced liver injury (DILI) after treatment with infliximab could be important in increasing the safety of infliximab use. We performed a genetic analysis to identify possible human leukocyte antigen (HLA) associations with DILI in European Caucasian users of infliximab in a retrospective study of 16 infliximab-DILI patients and 60 matched controls. In...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Inflammatory Agents
Share to Chemical and Drug Induced Liver Injury

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to HLA Antigens

Share to HLA-B8 Antigen

Share to HLA-DQ beta-Chains

Share to HLA-DRB1 Chains

Share to Infliximab

Share to Pharmacogenomic Variants

Source

Identifiers

PMID: 32024945
DOI: 10.1038/s41397-020-0159-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HLA associations with infliximab-induced liver injury.PMID 32024945Read ↗

Genetic risk factors in the development of idiosyncratic drug-induced liver injury.Semantic proximity Read ↗

Autoantibody presentation in drug-induced liver injury and idiopathic autoimmune hepatitis: the influence of human leucocyte antigen alleles.Semantic proximity Read ↗

In silicoanalysis of HLA associations with drug-induced liver injury: use of a HLA-genotyped DNA archive from healthy volunteersSemantic proximity Read ↗

Human leukocyte antigen genetic risk factors of drug-induced liver toxicology.Semantic proximity Read ↗

Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles.Semantic proximity Read ↗

Extended Analysis Identifies Drug-Specific Association of 2 Distinct HLA Class II Haplotypes for Development of Immunogenicity to Adalimumab and InfliximabSemantic proximity Read ↗

[Genetic susceptibility to drug-induced liver injury].Semantic proximity Read ↗

HLA and autoimmune digestive disease: a clinically oriented review for gastroenterologists.Semantic proximity Read ↗

Human Leukocyte Antigen (HLA) Signatures and Idiosyncratic Drug-Induced Liver Injury.Semantic proximity Read ↗

Allopurinol hepatotoxicity is associated with human leukocyte antigen Class I alleles.Semantic proximity Read ↗

Drug‐Induced Liver Injury due to Flucloxacillin: Relevance of Multiple Human Leukocyte Antigen AllelesSemantic proximity Read ↗

Immune-Mediated Drug-Induced Liver Injury: Immunogenetics and Experimental Models.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.